Materialise NV (MTLS) Q2 2026 Earnings Call Transcript
Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.
Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| NA Nizar Araji National Bank Of Canada /FI/ | 130 | $2,809.3 | $1,055.6 | -$1,753.7 | -62.42% |
| KMT Kirk M. Tokheim Ameritas Advisory Services LLC | 34 | $226.1 | $276.08 | $49.98 | 22.11% |
Taro Kuriyama Axq Capita LLP | 15,934 | $105,961.1 | $129,463.75 | $23,502.65 | 22.18% |
Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $9.88 | $16.24 | $6.36 | 64.37% |
Christopher C. Powers Farther Finance Advisors, LLC | 1,176 | $9,149.28 | $9,584.4 | $435.12 | 4.76% |
| Software Industry | Information Technology Sector | Brigitte de Vet-Veithen CEO | NASDAQ (NGS) Exchange | 57667T100 CUSIP |
| BE Country | 2,556 Employees | - Last Dividend | - Last Split | 25 Jun 2014 IPO Date |
Materialise NV stands as a pivotal provider in the realms of additive manufacturing and medical software, coupled with 3D printing services, which spans across the Americas, Europe and Africa, and the Asia-Pacific. With its operational foundation laid down in 1990 and headquartered in Leuven, Belgium, Materialise NV has compartmentalized its expertise into three primary segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The company has fostered collaborative agreements with eminent entities like Zimmer Biomet Holdings, Inc., Encore Medical, L.P., DePuy Synthes Companies of Johnson & Johnson, and several others, demonstrating its industry significance and widespread trust. This extensive collaboration network underscores Materialise NV's influential role in advancing 3D printing applications within both industrial and medical frameworks.
Facilitates and enhances 3D printing operations through a comprehensive suite of software programs and platforms. This segment bridges various 3D printers with numerous software applications and capturing technologies, including CAD/CAM packages and 3D scanners. Its target clientele encompasses 3D printing machine manufacturers, production companies, and contract manufacturers across industries such as automotive, aerospace, consumer goods, and hearing aids, in addition to 3D printing service bureaus. Distribution is achieved via a direct sales force, a dedicated website, and through third-party resellers.
Focuses on delivering medical software that facilitates the analysis, planning, and engineering based on medical imaging, as well as the patient-specific design and printing of surgical devices and implants. This segment's offerings are primarily directed at medical device companies, hospitals, universities, research institutes, and industrial entities. Distribution is steered through direct sales efforts, the company's website, and Picture Archiving Communication Systems (PACS), underscoring Materialise's pivotal role in innovating medical procedures and patient care.
Provides 3D printing services alongside design and engineering services, catering to the rapid prototyping and additive manufacturing needs of production parts for industrial and commercial clients. This segment encapsulates Materialise NV's direct contribution to the manufacturing industry, showcasing its capabilities in turning conceptual designs into tangible, high-quality parts and products through state-of-the-art 3D printing technologies.